Iqvia Holdings (IQV) Other Non-Current Assets (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Other Non-Current Assets came in at $558.0 million in Q2 2026, up 8.77% year-over-year from $513.0 million in Q2 2025, and up 14.11% quarter-over-quarter from $489.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $558.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 8.77% year-over-year to $558.0 million; the TTM figure through Jun 2026 stood at $558.0 million (up 8.77% YoY), while the FY2025 annual figure was $505.0 million, down 2.88% from the prior year.
- Other Non-Current Assets came in at $558.0 million for Q2 2026 at Iqvia Holdings, up from $489.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $558.0 million in Q2 2026 to a low of $435.0 million in Q2 2023.
- Average Other Non-Current Assets over 5 years is $486.5 million, with a median of $481.5 million recorded in 2024.
- Year-over-year, Other Non-Current Assets soared 38.95% in 2022 and fell 11.36% in 2023.
- Over 5 years, Other Non-Current Assets stood at $472.0 million in 2022, then declined by 3.6% to $455.0 million in 2023, then climbed by 14.29% to $520.0 million in 2024, then declined by 2.88% to $505.0 million in 2025, then grew by 10.5% to $558.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $558.0 million in Q2 2026, $489.0 million in Q1 2026, and $505.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 117.41 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 587.56 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 201,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 91,801.74 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 558.00 Mn |
| Mar 31, 2026 | 489.00 Mn |
| Dec 31, 2025 | 505.00 Mn |
| Sep 30, 2025 | 474.00 Mn |
| Jun 30, 2025 | 513.00 Mn |
| Mar 31, 2025 | 485.00 Mn |
| Dec 31, 2024 | 520.00 Mn |
| Sep 30, 2024 | 467.00 Mn |
| Jun 30, 2024 | 478.00 Mn |
| Mar 31, 2024 | 476.00 Mn |
| Dec 31, 2023 | 455.00 Mn |
| Sep 30, 2023 | 459.00 Mn |
| Jun 30, 2023 | 435.00 Mn |
| Mar 31, 2023 | 468.00 Mn |
| Dec 31, 2022 | 472.00 Mn |
| Sep 30, 2022 | 488.00 Mn |
| Jun 30, 2022 | 487.00 Mn |
| Mar 31, 2022 | 528.00 Mn |
| Dec 31, 2021 | 491.00 Mn |
| Sep 30, 2021 | 411.00 Mn |